Tag Archives: Sarepta

The Food and Drug Administration will ask Sarepta Therapeutics to halt all shipments of its marketed gene therapy for Duchenne muscular dystrophy, a source familiar with the matter confirmed to BioPharma Dive. Sarepta last month paused shipments for certain older Duchenne patients following the death from acute liver failure of a second teenager treated with the therapy, called Elevidys. The …

Exclusive: US FDA to ask Sarepta to stop shipments of gene therapy Elevidys, source says  Reuters Sarepta shares plunge 40% as future of its gene therapy appears at risk  CNBC FDA to Ask Sarepta to Stop Shipping Muscular Dystrophy Drug Elevidys  The New York Times Third death from a Sarepta gene therapy  BioCentury FDA Is Investigating If Sarepta’s Gene Therapy Should Stay on Market  Bloomberg …

Douglas Ingram, president and chief executive officer of Sarepta Therapeutics Inc., during the Forbes Healthcare Summit in New York, US, on Tuesday, Dec. 5, 2023. Michael Nagle | Bloomberg | Getty Images Shares of Sarepta Therapeutics plunged more than 30% on Friday as the future of its approved gene therapy treatment appeared at risk. The Food and Drug Administration will …

Sarepta Says Another Patient Died After Receiving Gene Therapy  Bloomberg Patient dies in Sarepta gene therapy trial, adding to safety concerns  STAT Sarepta Therapeutics lays off one-third of workforce in drastic cost-cutting  The Boston Globe Third death from a Sarepta gene therapy  BioCentury Sarepta Therapeutics Stock Is Surging After The Bell: What’s Going On?  Yahoo Finance Source link

Sarepta Stock Soars. Why Layoffs and a ‘Black-Box’ Warning Are Good News.  Barron’s Sarepta Therapeutics lays off one-third of workforce in drastic cost-cutting  The Boston Globe Sarepta Soars as Gene Therapy Stays on Market With Warning  Bloomberg Sarepta to lay off about 500 employees after Duchenne gene therapy setbacks  BioPharma Dive Sarepta pivots to siRNA and lays off 500 staffers as Elevidys gets box …

TSMC, United, Sarepta, PepsiCo, GE Aerospace, MP Materials, Archer Daniels, and More Movers  Barron’s Stocks making the biggest premarket moves: PepsiCo, Starbucks, General Electric, Cars.com and more  CNBC Stocks to Watch Thursday: TSMC, United Airlines, GE Aerospace  The Wall Street Journal Stock Movers: Lucid, United, GE  Bloomberg Netflix, PepsiCo and GE Aerospace rise premarket; United Airlines falls  Investing.com Source link

Sarepta Therapeutics to Restructure, Lay Off 500 Workers  The Wall Street Journal Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label  Sarepta Therapeutics Sarepta Stock Soars 30%. Why Layoffs and a ‘Black-Box’ Warning Are Good News.  Barron’s Sarepta Soars as Gene Therapy Stays on Market With Warning  Bloomberg Sarepta Tags DMD Gene Therapy …

Sarepta to cut 500 jobs, add black-box warning on gene therapy  Reuters Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label  Sarepta Therapeutics Sarepta Soars as Gene Therapy Stays on Market With Warning  Bloomberg Sarepta pivots to siRNA and lays off 500 staffers as Elevidys gets box warning  Fierce Biotech Sarepta Therapeutics Halts …

Sarepta Soars as Gene Therapy Stays on Market With Warning  Bloomberg Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label  Sarepta Therapeutics Sarepta pivots to siRNA and lays off 500 staffers as Elevidys gets box warning  Fierce Biotech Sarepta Therapeutics Halts ELEVIDYS Shipments for Non-Ambulatory DMD Patients  Yahoo Finance Sarepta Therapeutics lays off …

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. You can reach Adam on Signal at stataf.54. Sarepta Therapeutics laid off more than one-third of its workforce, …